The Filing Desk

Alto Ingredients vs Ingevity

Alto Ingredients ALTO · Ingevity NGVT · Specialty Chemicals

Ingevity reported revenue of $1.2 billion in fiscal 2025, 1.3 times Alto Ingredients' $918 million in fiscal 2025. Alto Ingredients' revenue fell 4.9% in its latest year, and Ingevity's fell 2.7%. Alto Ingredients had an operating margin of 0.8%, against 35.9% at Ingevity. Free cash flow was $9 million at Alto Ingredients and $274 million at Ingevity.

Side by side

Alto IngredientsIngevity
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$918M$1.2B
Revenue growth−4.9%−2.7%
Revenue growth a year, last 5 years0.5%−0.8%
Gross margin3.8%39.5%
Operating margin0.8%35.9%
Net margin1.4%−14.3%
Free cash flow$9M$274M
Free cash flow margin0.9%23.4%
Return on capital2.5%24.6%
Net debt to EBITDA1.9x2.1x
Dividends and buybacks$0M$56M
Change in diluted share count3.0%−0.3%
Last close$3.66$61.72
P/E at the last close5.6×35.7×
Insider trades, last 12 monthsbought $361,250, sold $0sold $1.8 million
Piotroski F-score6 of 96 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Alto IngredientsIngevity
Operating margin
Percent of revenue
Alto IngredientsIngevity
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Alto IngredientsIngevity

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Alto Ingredients and Ingevity pages.